Skip to main content
. 2022 Jul 27:10.2217/imt-2022-0015. doi: 10.2217/imt-2022-0015

Figure 3. Survival rate of Syrian hamsters.

Figure 3.

Survival was evaluated in animals treated with COVID-globulin, normal intravenous immunoglobulin and placebo at the indicated days after inoculation with SARS-CoV-2. Group 1 received COVID-globulin 24 h before infection; group 2 received COVID-globulin 2 h after infection; group 3 received COVID-globulin 48 h after infection; group 4 was treated with normal intravenous immunoglobulin; group 5 was treated with placebo.

COVID-globulin: Anti-COVID-19 hyperimmune immunoglobulin; IVIG: Intravenous immunoglobulin.